Biography

Gerry is the founding Chair of the firm’s Intellectual Property Department and centers his practice on guiding clients through their most consequential intellectual property disputes and transactions.

Leader of the firm’s Pharma & Biotech Group, Gerry is a seasoned litigator whose career is defined by resolving complex patent and business disputes for clients across the pharmaceutical, biotechnology, chemical, and medical device industries. He advises and represents Fortune 100 companies, universities, emerging companies and nonprofits in guarding their IP assets and innovation.

A trusted adviser, Gerry helps clients adopt and execute a comprehensive IP strategy grounded in protecting assets, avoiding risk and optimizing revenue. He has litigated disputes involving patents, trademarks, copyrights, trade dress, trade secrets and breach of contract.

Gerry’s philosophy is straightforward: a client’s legal problem becomes his own. A gifted storyteller, he approaches litigation as a narrative exercise — building clear, compelling themes that judges and juries can grasp, while mapping efficient strategies to protect or resolve the matter. Whether shaping an early settlement or preparing for trial, Gerry develops a narrative that will drive results, always balancing forceful advocacy with cost-effective execution.

His services include:

  • Strategic counseling: Advising on the validity and scope of intellectual property rights, portfolio development, opinion work, and risk evaluation in the life sciences and medical device sectors.
  • Transactions and corporate matters: Conducting due diligence in multibillion-dollar mergers, acquisitions, divestitures, and licensing, including representing a biotechnology company in an $8.4 billion merger.
  • Litigation and proceedings: Representing clients in patent, trademark, copyright, trade secret, and contract disputes, as well as in USPTO Inter Partes Reviews and Reexaminations.

A leader at the firm for many years, Gerry previously served as Managing Partner of the Princeton office and was a member of the Executive Committee.

Gerry is the founding Chair of the firm’s Intellectual Property Department and centers his practice on guiding clients through their most consequential intellectual property disputes and transactions.

Leader of the firm’s Pharma & Biotech Group, Gerry is a seasoned litigator whose career is defined by resolving complex patent and business disputes for clients across the pharmaceutical, biotechnology, chemical, and medical device industries. He advises and represents Fortune 100 companies, universities, emerging companies and nonprofits in guarding their IP assets and innovation.

A trusted adviser, Gerry helps clients adopt and execute a comprehensive IP strategy grounded in protecting assets, avoiding risk and optimizing revenue. He has litigated disputes involving patents, trademarks, copyrights, trade dress, trade secrets and breach of contract.

Gerry’s philosophy is straightforward: a client’s legal problem becomes his own. A gifted storyteller, he approaches litigation as a narrative exercise — building clear, compelling themes that judges and juries can grasp, while mapping efficient strategies to protect or resolve the matter. Whether shaping an early settlement or preparing for trial, Gerry develops a narrative that will drive results, always balancing forceful advocacy with cost-effective execution.

His services include:

  • Strategic counseling: Advising on the validity and scope of intellectual property rights, portfolio development, opinion work, and risk evaluation in the life sciences and medical device sectors.
  • Transactions and corporate matters: Conducting due diligence in multibillion-dollar mergers, acquisitions, divestitures, and licensing, including representing a biotechnology company in an $8.4 billion merger.
  • Litigation and proceedings: Representing clients in patent, trademark, copyright, trade secret, and contract disputes, as well as in USPTO Inter Partes Reviews and Reexaminations.

A leader at the firm for many years, Gerry previously served as Managing Partner of the Princeton office and was a member of the Executive Committee.

Before Fox Rothschild

Gerry held a post-doctoral fellowship with Merck after he earned a B.A. in biology from Fordham College and a Ph.D. in Microbiology, Virology and Immunology from Mount Sinai School of Medicine. He went on to earn a law degree from Fordham University School of Law.

Previously in his legal career, Gerry was an attorney at Rogers & Wells and at Clifford Chance in New York, and subsequently was a named partner of an IP boutique law firm in New Jersey.

Bar Admissions

  • New Jersey
  • New York
  • U.S. Patent & Trademark Office

Court Admissions

  • U.S. Supreme Court
  • U.S. Court of Appeals, Federal Circuit
  • U.S. Court of Appeals, Second Circuit
  • U.S. District Court, Northern District of Indiana
  • U.S. District Court, District of New Jersey
  • U.S. District Court, Southern District of New York
  • U.S. District Court, Eastern District of New York

Education

  • Fordham University School of Law (J.D.)
  • Mount Sinai School of Medicine (Ph.D.)
    • in Microbiology, Virology and Immunology
  • Fordham College (B.A.)
    • Biology

Memberships

  • American Bar Association
  • American Association for Justice
  • American Intellectual Property Law Association
  • New Jersey State Bar Association
  • New York State Bar Association
  • New York Intellectual Property Law Association